Article
Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
Stroke - 1 Aug 2005
Wiklund Per-Gunnar, Nilsson Lennart, Ardnor Sofie Nilsson, Eriksson Per, Johansson Lars, Stegmayr Birgitta, Hamsten Anders, Holmberg Dan, Asplund Kjell
Abstract excerpt
BACKGROUND AND PURPOSE: Impaired fibrinolytic function secondary to elevated plasminogen activator inhibitor-1 (PAI-1) levels has been implicated in ischemic stroke. PAI-1 levels are determined by genetic factors and environmental factors, triglyceride levels in particular. The aim of this study was to investigate the common functional 4/5 guanosine (4G/5G) polymorphism in the promoter region of the PAI-1 gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
